AI, Genomics, and CRISPR Signal a New Phase of Biological Innovation
KRAIG BIOCRAFT LABS INC (KBLB)
NASDAQ:AMEX Investor Relations:
kraiglabs.com/investors
Company Research
Source: GlobeNewswire
DENVER, Feb. 10, 2026 (GLOBE NEWSWIRE) -- As artificial intelligence continues to move beyond software and automation, its impact on genomics and gene editing is becoming increasingly tangible. Recent developments among genomics and AI-enabled biotechnology companies suggest that AI-driven pattern recognition is emerging as a foundational layer for CRISPR-based innovation, with implications spanning human health and advanced biologically assembled materials. Illumina (NASDAQ: ILMN), the global leader in DNA sequencing, recently secured U.S. Medicare reimbursement for its TruSight™ Oncology Comprehensive test, expanding access to broad genomic profiling in routine cancer care. Increased reimbursement-driven adoption is expected to significantly expand the volume of clinically relevant genomic data entering research and analytics pipelines. In parallel, Illumina has announced large-scale cell-mapping initiatives designed to catalog genomic responses across billions of cells. These da
Show less
Read more
Impact Snapshot
Event Time:
KBLB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KBLB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KBLB alerts
High impacting KRAIG BIOCRAFT LABS INC news events
Weekly update
A roundup of the hottest topics
KBLB
News
- Kraig Biocraft Laboratories Deploys Over 700,000 BAM-1 Alpha Production Hybrids, Achieving Key Milestone in its Aggressive Scale-Up PlanGlobeNewswire
- Kraig Biocraft Laboratories Increases R&D Capacity, as Project Atlas Breakthroughs Creating New Spider Silk TransgenicsGlobeNewswire
- Engineered Silkworms Spin Spider Silk as Biotech Firm Targets Commercial ScaleGlobeNewswire
- 24/7 Market News: Kraig Labs the Bootstrapped Unicorn in the MakingGlobeNewswire
- Kraig Biocraft Laboratories Targets New Industrial and Defense Biomaterials as "Project Atlas" Hits Major MilestoneGlobeNewswire
KBLB
Sec Filings
- 3/30/26 - Form 10-K
- 2/18/26 - Form 8-K
- KBLB's page on the SEC website